Theralase(R) Extends Warrants

TORONTO, ON / ACCESSWIRE / September 19, 2024 / Theralase Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or …
Jetzt den vollständigen Artikel lesen